Battistini B, Woods M, O'Donnell L J, Warner T D, Corder R, Fournier A, Farthing M J, Vane J R
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, U.K.
Br J Pharmacol. 1995 Apr;114(7):1383-90. doi: 10.1111/j.1476-5381.1995.tb13359.x.
A single addition of 3 x I0-7 M ET-1, ET-2 or ET-3 produced contractions that reached a steady state in 28.2 +/- 4.2, 21.1 +/- 1.3 and 24.0 +/- 3.8 min, respectively and took 2.7 +/- 0.4, 2.1 + 0.1 and 1.6 +/- 0.1 min to reach half of this steady-state response.4. Contractions induced by 3 x I0-7 M big ET-11-38 or big ET-11- 39 reached a plateau in 38.5 +/- 3.6 and 35.6 +/- 3.3 min, respectively, and half of these responses were attained in 12.0 +/- 2.5 and 7.1 +/- 1.1 min.Thus, these contractions developed more slowly than those induced by ET-1. Contractions induced by 3 x 10-7 M big ET-21-38 were also much slower to develop than those to ET-2, for these took 49 +/- 2 min to reach plateau and 19.4 +/- 2.1 min to attain half that response. Contractions induced by 3 x 10-7 M big ET-31-41 amide took 50.2 +/- 3.7 min to reach a plateau and 27.3 +/- 3.0 min to reach half of this response.5. Phosphoramidon (0.1, 1 and 3 x 10-4 M) inhibited contractions induced by big ET-11.39. For instance,the contractions induced by 3 x 10-7 M big ET-11-39 were inhibited by 10-4 M or 3 x 10-4 M of phosphoramidon by 62.8 +/- 6.7% or 74.5 +/- 4.6%, respectively. Similarly, contractions induced by ET-21-38 were inhibited by 91.3 +/- 5.4% and the small response induced by big ET-3l-4l amide was abolished by 3 x 10-4M phosphoramidon. Conversely, the neutral endopeptidase (EC 24.11) inhibitor DL-thiorphan(3 x 10-4 M) had no effect. Captopril (10-5 M), pepstatin A (10-5 M), phenylmethylsulphonylfluoride(PMSF, 10-3 M), aprotinin (10-5 M), E-64 (10-5 M), cystatin (10-6 M), leupeptin (10-4 M),chymostatin (10-4 M), or bestatin (10-5 M) did not inhibit but rather increased to a similar, but small degree the contractions induced by 3 to 30 x 10-9 M big ET-11-39. Only captopril (10-5 M) or leupeptin(10-4 M) increased the contraction induced by 3 x 10-7 M big ET-11-39. Phosphoramidon (10-4 M),pepstatin (10-5 M) or PMSF (10-3 M) did not affect contractions induced by ET-1.6. Removal of the epithelium increased by 70% the size of the contraction induced by 5 microM histamine(1.08 +/- 0.05 g; n = 160 to 1.84 +/- 0.14 g; n = 12) but did not affect, in absolute terms, the contraction induced by ET-1 (as a % of the response to histamine, these responses were, of course, apparently depressed). Epithelium removal did, however, increase the size of the contractions induced by 3 to 30 x 10-9 M big ET-1 -39 which was very similar to the effect of the protease inhibitors.7. In competition binding studies on membranes prepared from the guinea-pig gallbladder, 10-11 MET-1 inhibited by 76.9 +/- 3.1% the binding of [125]-ET-I while porcine big ET-11-39 caused no inhibition(0.7 +/- 3.0; n = 3). ET-1 (10-6 M) inhibited binding by 95.7 =/- 1.1% (n = 3) while at this much higher concentration, big ET-11-39 inhibited binding by only 16.8 +/- 4.2% (n = 3). This clearly suggests that big ET-11-39 does not bind directly to ET receptors.8. Thus, a phosphoramidon-sensitive endothelin-converting enzyme (ECE), different from neutral endopeptidase (NEP; EC 24.11) and not located on the epithelium, converts big ET-1 into ET-1 in the gallbladder of the guinea-pig. This ECE appears to act preferentially on big ET-1 or big ET-2 over bigET-3.
单次添加3×10⁻⁷ M的ET - 1、ET - 2或ET - 3会引发收缩,分别在28.2±4.2分钟、21.1±1.3分钟和24.0±3.8分钟达到稳态,达到该稳态反应一半所需时间分别为2.7±0.4分钟、2.1±0.1分钟和1.6±0.1分钟。4. 3×10⁻⁷ M的big ET - 11 - 38或big ET - 11 - 39引发的收缩分别在38.5±3.6分钟和35.6±3.3分钟达到平台期,达到这些反应一半所需时间分别为12.0±2.5分钟和7.1±1.1分钟。因此,这些收缩的发展比ET - 1引发的收缩更慢。3×10⁻⁷ M的big ET - 21 - 38引发的收缩发展也比ET - 2引发的收缩慢得多,因为这些收缩需要49±2分钟达到平台期,19.4±2.1分钟达到该反应的一半。3×10⁻⁷ M的big ET - 31 - 41酰胺引发的收缩需要50.2±3.7分钟达到平台期,27.3±3.0分钟达到该反应的一半。5. 磷酰胺素(0.1、1和3×10⁻⁴ M)可抑制big ET - 11.39引发的收缩。例如,3×10⁻⁷ M的big ET - 11 - 39引发的收缩,10⁻⁴ M或3×10⁻⁴ M的磷酰胺素分别抑制62.8±6.7%或74.5±4.6%。同样,ET - 21 - 38引发的收缩被抑制91.3±5.4%,3×10⁻⁴ M的磷酰胺素可消除big ET - 3l - 4l酰胺引发的小反应。相反,中性内肽酶(EC 24.11)抑制剂DL - 硫氧还蛋白(3×10⁻⁴ M)没有作用。卡托普利(10⁻⁵ M)、胃蛋白酶抑制剂A(10⁻⁵ M)、苯甲基磺酰氟(PMSF,10⁻³ M)、抑肽酶(10⁻⁵ M)、E - 64(10⁻⁵ M)、胱抑素(10⁻⁶ M)、亮抑肽酶(10⁻⁴ M)、糜蛋白酶抑制剂(10⁻⁴ M)或贝司他汀(10⁻⁵ M)均不抑制,反而在一定程度上使3至30×10⁻⁹ M的big ET - 11 - 39引发的收缩略有增加。只有卡托普利(10⁻⁵ M)或亮抑肽酶(10⁻⁴ M)可增加3×l0⁻⁷ M的big ET - 11 - 39引发的收缩。磷酰胺素(10⁻⁴ M)、胃蛋白酶抑制剂(10⁻⁵ M)或PMSF(10⁻³ M)不影响ET - 1引发的收缩。6. 去除上皮组织后,5微摩尔组胺引发的收缩大小增加70%(从1.08±0.05克;n = 160增加到1.84±0.14克;n = 12),但就绝对值而言,不影响ET - 1引发的收缩(当然,这些反应相对于组胺反应的百分比明显降低)。然而,去除上皮组织确实增加了3至30×10⁻⁹ M的big ET - 1 - 39引发的收缩大小,这与蛋白酶抑制剂的作用非常相似。7. 在豚鼠胆囊制备的膜的竞争结合研究中,10⁻¹¹ M的ET - 1抑制[¹²⁵] - ET - I的结合达76.9±3.1%,而猪big ET - 11 - 39无抑制作用(0.7±3.0;n = 3)。ET - 1(10⁻⁶ M)抑制结合达95.7±1.1%(n = 3),而在此更高浓度下,big ET - 11 - 39仅抑制结合16.8±4.2%(n = 3)。这清楚地表明big ET - 11 - 39不直接与ET受体结合。8. 因此,在豚鼠胆囊中,一种对磷酰胺素敏感的内皮素转化酶(ECE),不同于中性内肽酶(NEP;EC 24.11)且不在上皮组织上,将big ET - 1转化为ET - 1。这种ECE似乎对big ET - 1或big ET - 2的作用优先于big ET - 3。